期刊文献+

醋酸奥曲肽微球治疗胃肠胰腺神经内分泌肿瘤的疗效观察 被引量:5

The curative effect of octreotide acetate microsphere in the treatment of gastroenteropancreatic neuroendocrine neoplasms
下载PDF
导出
摘要 目的探讨醋酸奥曲肽微球治疗胃肠胰腺神经内分泌肿瘤(GEP-NENs)的疗效。方法选择2017年11月至2019年3月我科收治GEP-NENs患者70例,随机数字表法分为GEM组及OA+GEM组各35例。GEM组采用吉西他滨(GEM)治疗,OA+GEM组采用GEM联合醋酸奥曲肽(OA)微球治疗。比较两组近期、短期远期疗效、治疗前后肿瘤标志物水平、血清激素水平、治疗后KPS评分与QOL-BREF评分及安全性。结果治疗后,OA+GEM组近期、短期远期疗效均优于GEM组,治疗有效率、疾病控制率与复发率比较,差异有统计学意义(P<0.05);治疗后,两组神经元特异性烯醇化酶(NSE)、嗜铬粒蛋白A(CgA)及癌胚抗原(CEA)水平低于治疗前,且OA+GEM组低于GEM组;两组胰岛素水平与治疗前比较显著上升,胃泌素以及胰高血糖素较治疗前显著降低,且治疗后OA+GEM组胰岛素水平高于GEM组,胃泌素与胰高血糖素水平低于GEM组,差异有统计学意义(P<0.05);OA+GEM组治疗后KPS评分与QOL-BREF评分明显优于GEM组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论OA微球治疗GEP-NENs可以明显改善患者肿瘤标志物水平,纠正患者体内紊乱胰岛素、胃泌素与胰高血糖素水平,治疗有效率高,安全性高。 Objective To explore the curative effect of octreotide acetate(OA)microsphere in the treatment of gastroenteropancreatic neuroendocrine neoplasms(GEP-NENs).Methods Seventy patients with GEP-NENs who were treated in our department from November 2017 to March 2019 were selected as the subjects.They were divided into gemcitabine(GEM)group and OA+GEM group by the random number table method,35 in each group.The GEM group was treated with GEM while the OA+GEM group was treated with GEM+OA microsphere.The short-term and long-term curative effect,levels of tumor markers and serum hormones before and after treatment,KPS scores and QOL-BREF scores after treatment and safety were compared between the two groups.Results After treatment,the short-term and long-term curative effect in the OA+GEM group were better than those in the GEM group.Besides,the differences in treatment response rate,disease control rate and recurrence rate were statistically significant(P<0.05).After treatment,NSE,CEA and CgA levels in both groups were significantly decreased(P<0.05),and levels of above indexes in the OA+GEM group were lower than those in the GEM group(P<0.05).After treatment,insulin levels in both groups were significantly increased,while gastrin and glucagon levels were significantly decreased.After treatment,insulin level in the OA+GEM group was higher than that in the GEM group,while gastrin and glucagon levels were lower than those in the GEM group(P<0.05).After treatment,scores of KPS and QOL-BREF in the OA+GEM group were significantly better than those in the GEM group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The application of OA microsphere in the treatment of GEP-NENs can significantly improve the levels of tumor markers and correct the disordered levels of insulin,gastrin and glucagon in the patients.The response rate and safety are high,and recurrence is little.
作者 叶显辉 兰尧 许辉琼 YE Xian-hui;LAN Yao;XU Hui-qiong(Department of Abdominal Oncology,West China Hospital,Sichuan University,Chengdu 610041,China)
出处 《实用医院临床杂志》 2020年第4期136-139,共4页 Practical Journal of Clinical Medicine
关键词 醋酸奥曲肽微球 胃肠胰腺神经内分泌肿瘤 疗效 Octreotide acetate microsphere Gastroenteropancreatic neuroendocrine neoplasm Curative effect
  • 相关文献

参考文献10

二级参考文献67

共引文献338

同被引文献52

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部